| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Children's Hospital Research Foundation, Department of Pediatrics, Division of Molecular Cardiovascular Biology, Cincinnati, Ohio 45229-3039
A number of techniques are now available that allow the contractile apparatus of the heart to be altered in a defined manner. This review focuses on those approaches that result in germ-line transmission of the remodeling event(s). Thus the desired modifications can be propagated stably throughout multiple generations and result in the creation of stable, new animal models. Necessarily, such stable changes need to be performed at the level of the genome, and two distinct but complementary approaches have been developed: transgenesis and gene targeting. Each results in the stable modification of the mammalian genome. Via gene targeting or gene ablation of sequences encoding various components of the sarcomere, the contractile apparatus of the heart can be altered dramatically. Ablating a gene may lead to a loss in function, which can help establish a function of the candidate sequence. Gene targeting can also be used to effect changes in the sequences encoding a functional domain of the contractile protein or at a single-amino acid residue, resulting in the establishment of precise structure-function relationships. With the use of transgenesis, the contractile apparatus of the heart can also be significantly remodeled. These approaches are rapidly creating a group of animals in which altered contractile protein complements will lead to a fundamental understanding of the structure-function relationships that underlie the function of the heart at the molecular, biochemical, whole organ, and whole animal levels.
contractile proteins; genetics; transgenic; gene targeting
This article has been cited by other articles:
|
|
 |
|
  J. M. Metzger, D. E. Michele, E. M. Rust, A. R. Borton, and M. V. Westfall Sarcomere Thin Filament Regulatory Isoforms. EVIDENCE OF A DOMINANT EFFECT OF SLOW SKELETAL TROPONIN I ON CARDIAC CONTRACTION J. Biol. Chem., April 4, 2003; 278(15): 13118 - 13123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sanbe, J. Gulick, E. Hayes, D. Warshaw, H. Osinska, C.-B. Chan, R. Klevitsky, and J. Robbins Myosin light chain replacement in the heart Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1355 - H1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. James, A. Sanbe, K. Yager, L. Martin, R. Klevitsky, and J. Robbins Genetic Manipulation of the Rabbit Heart via Transgenesis Circulation, April 11, 2000; 101(14): 1715 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Belke, T. S. Larsen, G. D. Lopaschuk, and D. L. Severson Glucose and fatty acid metabolism in the isolated working mouse heart Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1210 - R1217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Michele, F. P. Albayya, and J. M. Metzger Thin Filament Protein Dynamics in Fully Differentiated Adult Cardiac Myocytes: Toward A Model of Sarcomere Maintenance J. Cell Biol., June 28, 1999; 145(7): 1483 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Olson and J. D. Molkentin Prevention of Cardiac Hypertrophy by Calcineurin Inhibition : Hope or Hype? Circ. Res., April 2, 1999; 84(6): 623 - 632. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Sussman, H. W. Lim, N. Gude, T. Taigen, E. N. Olson, J. Robbins, M. C. Colbert, A. Gualberto, D. F. Wieczorek, and J. D. Molkentin Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition Science, September 11, 1998; 281(5383): 1690 - 1693. [Abstract] [Full Text]
|
|
|
|
|
|
J. Robbins {alpha}-Tropomyosin Knockouts : A Blow Against Transcriptional Chauvinism Circ. Res., January 23, 1998; 82(1): 134 - 136. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
